[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medpace Holdings Inc 5375 MEDPACE WAY CINCINNATI OH 45227 USA

www.medpace.com Employees: 6,200 P: 513-579-9911

Sector:

Medical

Description:

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

Key Statistics

Overview:

Market Capitalization, $K 12,769,456
Enterprise Value, $K 12,272,406
Shares Outstanding, K 28,560
Float, K 22,705
% Float 79.50%
Short Interest, K 1,551
Short Float 5.43%
Days to Cover 2.50
Short Volume Ratio 0.70
% of Insider Shareholders 20.50%
% of Institutional Shareholders 77.98%

Financials:

Annual Sales, $ 2,530 M
Annual Net Income, $ 451,120 K
Last Quarter Sales, $ 706,600 K
Last Quarter Net Income, $ 123,870 K
EBIT, $ 591,020 K
EBITDA, $ 619,140 K

Growth:

1-Year Return 52.18%
3-Year Return 110.84%
5-Year Return 164.25%
5-Year Revenue Growth 173.26%
5-Year Earnings Growth 282.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 4.28 on 04/22/26
Next Earnings Date 07/20/26
Earnings Per Share ttm 15.91
EPS Growth vs. Prev Qtr -8.35%
EPS Growth vs. Prev Year 16.62%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MEDP Ratios

Ratio
Price/Earnings ttm 28.17
Price/Earnings forward 26.30
Price/Earnings to Growth 2.27
Return-on-Equity % 120.89%
Return-on-Assets % 24.79%
Profit Margin % 17.83%
Debt/Equity 0.00
Price/Sales 5.06
Price/Cash Flow 26.34
Price/Book 21.39
Book Value/Share 20.95
Interest Coverage 41.44
60-Month Beta 1.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.